New imaging test aims to find hidden breast cancers earlier
NCT ID NCT03220893
Summary
This study tested whether adding a newer imaging test called molecular breast imaging (MBI) to standard 3D mammography (DBT) helps find more breast cancers in women with dense breast tissue. Researchers enrolled 3,023 women aged 40-75 with dense breasts who had no symptoms of breast disease. Participants received both screening methods annually for two years to compare how many invasive cancers each approach detected.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Henry Ford Hospital
Detroit, Michigan, 48202, United States
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
-
Mayo Clinic Health System-Franciscan Healthcare
La Crosse, Wisconsin, 54601, United States
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
-
Toledo Clinic Cancer Centers-Toledo
Toledo, Ohio, 43623, United States
Conditions
Explore the condition pages connected to this study.